Patient-derived organoids for personalized drug screening in intrahepatic cholangiocarcinoma

被引:0
|
作者
Antonia, Ricardo J.
Toriguchi, Kan
Karelehto, Eveliina
Annuar, Dania
Timmerman, Luika
Tbeileh, Noura
Mattis, Aras N.
Corvera, Carlos U.
Hirose, Kenzo
Nakakura, Eric K.
Donner, David B.
Warren, Robert S.
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] UCSF, San Francisco, CA USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
581
引用
收藏
页数:2
相关论文
共 50 条
  • [21] NSCLC patient-derived organoids to guide personalized therapy
    Kim, Seok-Young
    Kim, Dong Hwi
    Joo, Hyeong-Seok
    Yun, Mi Ran
    Lee, Ji Yeon
    Kim, Sang Min
    Kim, Hyunki
    Hong, Min Hee
    Kim, Hye Ryun
    Cho, Byoung Chul
    CANCER RESEARCH, 2019, 79 (13)
  • [22] Application of Patient-Derived Cancer Organoids to Personalized Medicine
    Shiihara, Masahiro
    Furukawa, Toru
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [23] Opportunities of patient-derived organoids in drug development
    Buening, Antonia
    Reckzeh, Elena
    BRITISH JOURNAL OF PHARMACOLOGY, 2025,
  • [24] Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy
    Narasimhan, Vignesh
    Wright, Josephine A.
    Churchill, Michael
    Wang, Tongtong
    Rosati, Rachele
    Lannagan, Tamsin R. M.
    Vrbanac, Laura
    Richardson, Anne B.
    Kobayashi, Hiroki
    Price, Timothy
    Tye, Gayle X. Y.
    Marker, Julie
    Hewett, Peter J.
    Flood, Michael P.
    Pereira, Shalini
    Whitney, G. Adam
    Michael, Michael
    Tie, Jeanne
    Mukherjee, Siddhartha
    Grandori, Carla
    Heriot, Alexander G.
    Worthley, Daniel L.
    Ramsay, Robert G.
    Woods, Susan L.
    CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3662 - 3670
  • [25] High-throughput screening of patient-derived HCC organoids for drug discovery
    Michelle, Alissa
    Wong, Go
    Cheung, Winnie
    Wong, Maggie
    Wong, Aikha
    Lam, Helena
    Zhang, Zhe
    Man, Matthew
    Chen, Hui
    Close, David
    Johnston, Paul
    Chan, Anthony
    Lai, Paul
    Kwong, Joseph
    Wong, Nathalie
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
    Wang, Zhiwei
    Guo, Yinghao
    Jin, Yun
    Zhang, Xiaoxiao
    Geng, Hao
    Xie, Guangyuan
    Ye, Dan
    Yu, Yuanquan
    Liu, Daren
    Zhou, Donger
    Li, Baizhou
    Luo, Yan
    Peng, Shuyou
    Li, Jiangtao
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [27] Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening
    Yang, Zhenjie
    Yu, Jun
    Wong, Chi Chun
    CELLS, 2024, 13 (16)
  • [28] Patient-Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
    Li, Zhichao
    Xu, Haibo
    Gong, Yanqing
    Chen, Wei
    Zhan, Yonghao
    Yu, Lei
    Sun, Yangyang
    Li, Aolin
    He, Shiming
    Guan, Bao
    Wu, Yucai
    Xiong, Gengyan
    Fang, Dong
    He, Yuhui
    Tang, Qi
    Yao, Lin
    Hu, Zheng
    Mei, Hongbing
    He, Zhisong
    Cai, Zhiming
    Guo, Yinglu
    Li, Xuesong
    Zhou, Liqun
    Huang, Weiren
    ADVANCED SCIENCE, 2022, 9 (04)
  • [29] Patient-derived parathyroid organoids as a tracer and drug-screening application model
    Noltes, Milou E.
    Sondorp, Luc H. J.
    Kracht, Laura
    Antunes, Ines F.
    Wardenaar, Rene
    Kelder, Wendy
    Kemper, Annelies
    Szymanski, Wiktor
    Zandee, Wouter T.
    Jansen, Liesbeth
    Brouwers, Adrienne H.
    Coppes, Robert P.
    Kruijff, Schelto
    STEM CELL REPORTS, 2022, 17 (11): : 2518 - 2530
  • [30] Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
    Zhiwei Wang
    Yinghao Guo
    Yun Jin
    Xiaoxiao Zhang
    Hao Geng
    Guangyuan Xie
    Dan Ye
    Yuanquan Yu
    Daren Liu
    Donger Zhou
    Baizhou Li
    Yan Luo
    Shuyou Peng
    Jiangtao Li
    Cancer Cell International, 21